See more : Alkim Alkali Kimya A.S. (ALKIM.IS) Income Statement Analysis – Financial Results
Complete financial analysis of Medicine Man Technologies, Inc. (SHWZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicine Man Technologies, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Nihon Kohden Corporation (NHNKF) Income Statement Analysis – Financial Results
- ICBS, Ltd. (ICBT) Income Statement Analysis – Financial Results
- Shanghai Dragon Corporation (600630.SS) Income Statement Analysis – Financial Results
- Azure Dynamics Corp. (AZDDQ) Income Statement Analysis – Financial Results
- Retail Food Group Limited (RFGPF) Income Statement Analysis – Financial Results
Medicine Man Technologies, Inc. (SHWZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.schwazze.com
About Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 172.45M | 159.38M | 108.42M | 24.00M | 10.62M | 7.92M | 3.53M | 631.46K | 835.78K | 251.89K |
| Cost of Revenue | 96.42M | 74.35M | 59.07M | 17.23M | 7.62M | 2.58M | 1.30M | 462.18K | 209.75K | 72.00K |
| Gross Profit | 76.02M | 85.03M | 49.35M | 6.77M | 3.00M | 5.35M | 2.23M | 169.27K | 626.03K | 179.89K |
| Gross Profit Ratio | 44.09% | 53.35% | 45.52% | 28.23% | 28.27% | 67.47% | 63.10% | 26.81% | 74.90% | 71.42% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 70.93M | 64.16M | 38.94M | 29.68M | 16.47M | 4.40M | 7.13M | 1.01M | 519.88K | 193.15K |
| Selling & Marketing | 0.00 | -34.77M | 0.00 | 0.00 | 0.00 | 291.71K | 183.78K | 311.52K | 16.00K | 15.50K |
| SG&A | 70.93M | 64.16M | 38.94M | 29.68M | 16.47M | 4.69M | 7.31M | 1.32M | 535.88K | 208.64K |
| Other Expenses | 1.80M | 24.14K | 22.33M | 32.62K | 11.99M | 1.37M | -70.04K | 165.02K | 0.00 | 0.00 |
| Operating Expenses | 72.73M | 64.16M | 38.94M | 29.68M | 16.47M | 4.69M | 7.31M | 1.32M | 535.88K | 208.64K |
| Cost & Expenses | 169.16M | 138.51M | 98.01M | 46.90M | 24.08M | 7.27M | 8.62M | 1.78M | 745.62K | 280.64K |
| Interest Income | 0.00 | 30.14M | 7.01M | 41.46K | 31.91K | 30.00K | 30.00K | 14.02K | 8.07K | 3.12K |
| Interest Expense | 32.07M | 30.14M | 7.01M | 41.46K | 192.11K | 0.00 | 86.02K | 125.16K | 0.00 | 1.18K |
| Depreciation & Amortization | 20.93M | 11.55M | 8.58M | 476.59K | 61.71K | 81.96K | 63.74K | 17.37K | 6.62K | 561.00 |
| EBITDA | 37.52M | 38.12M | 3.47M | -19.80M | -13.55M | 1.61M | -5.23M | -1.42M | 96.77K | -30.40K |
| EBITDA Ratio | 21.76% | 20.02% | 3.20% | -104.26% | -89.16% | 9.64% | -143.42% | -177.48% | 11.58% | -9.95% |
| Operating Income | 3.29M | 20.89M | -5.11M | -22.90M | -13.46M | 2.17M | -5.24M | -1.15M | 90.15K | -28.75K |
| Operating Income Ratio | 1.91% | 13.11% | -4.71% | -95.43% | -126.80% | 27.39% | -148.34% | -182.45% | 10.79% | -11.41% |
| Total Other Income/Expenses | -18.10M | -16.42M | 8.51M | 2.59M | -476.76K | -638.50K | -145.22K | -312.18K | 8.07K | 1.94K |
| Income Before Tax | -14.81M | -3.57M | 18.92M | -20.32M | -17.56M | 1.53M | -5.38M | -1.46M | 98.22K | -26.81K |
| Income Before Tax Ratio | -8.59% | -2.24% | 17.45% | -84.65% | -165.36% | 19.33% | -152.46% | -231.89% | 11.75% | -10.64% |
| Income Tax Expense | 19.74M | 14.90M | 4.40M | -899.11K | -582.93K | 582.93K | 15.98K | 125.16K | 12.48K | 3.14K |
| Net Income | -34.55M | -18.47M | 14.52M | -19.42M | -16.98M | 948.92K | -5.38M | -1.46M | 85.75K | -29.95K |
| Net Income Ratio | -20.03% | -11.59% | 13.39% | -80.90% | -159.87% | 11.97% | -152.46% | -231.89% | 10.26% | -11.89% |
| EPS | -0.26 | -0.34 | 0.17 | -0.47 | -0.50 | 0.03 | -0.23 | -0.14 | 0.01 | 0.00 |
| EPS Diluted | -0.26 | -0.34 | -0.06 | -0.47 | -0.50 | 0.03 | -0.23 | -0.14 | 0.01 | 0.00 |
| Weighted Avg Shares Out | 64.54M | 53.64M | 43.34M | 41.22M | 33.74M | 27.77M | 22.99M | 10.23M | 9.91M | 9.84M |
| Weighted Avg Shares Out (Dil) | 64.54M | 53.64M | 101.37M | 41.22M | 33.74M | 27.77M | 22.99M | 10.23M | 9.91M | 9.97M |
Schwazze to Host First Quarter 2021 Conference Call and Webcast - May 13, 2021
Cannabis Growth Operator, Schwazze, Announces Rebannering of Mesa Organics Stores to Star Buds Dispensaries in Colorado
Medicine Man Technologies' (SHWZ) CEO Justin Dye on Q4 2020 Results - Earnings Call Transcript
Schwazze to Host Fourth Quarter 2020 Conference Call and Webcast on March 30, 2021
Schwazze Appoints Jeff Cozad and Salim Wahdan to the Board of Directors
Schwazze Completes Acquisition of Five Remaining Star Buds Dispensaries in Colorado
Schwazze Completes Latest Financing Round
Schwazze Acquires Two Additional Star Buds Dispensaries in Colorado
Colorado-based Cannabis Collective, Schwazze, Announces Changes to Board of Directors
Schwazze Acquires Six Star Buds Dispensaries in Colorado
Source: https://incomestatements.info
Category: Stock Reports